Submission Deadline: March 30, 2020

Telehealth and Medicine Today (TMT) is inviting submissions for a special issue dedicated to Telehealth Innovations in Diabetes.

This special issue of Telehealth and Medicine Today (TMT) seeks to contribute to and advance research on diabetes mellitus management through publication of original research, use cases, and applications to share with innovators and leaders who are driving market use, adoption, and scale.  Collectively, health professionals are in this fight to find a cure, and it will require a cumulation of innovative solutions in order to eradicate diabetes.

Worldwide, approximately 425 million people are living with diabetes—30 million in the United States alone—with an incidence that has accelerated over the past eight decades. At the center of the diabetes global epidemic are the people living with diabetes and their caregivers. Whether prediabetes (elevated glucose levels but not in the diabetes range), type 1 diabetes (due to of environmental factors and genetics triggering autoimmunity), or type 2 diabetes (insulin secretion not keeping up with demand),1 the diagnosis can be life-changing for everyone involved.  

Among people with prediabetes, 90% (approximately 84 million) don’t know they have it.  Yet, as patients progress to diabetes mellitus, there is increased risk for serious complications if not treated properly. These include retinopathy, chronic kidney disease, limb amputation, heart disease and stroke.  Clearly, people living with diabetes are at the center of this global epidemic.  Fortunately, we have an opportunity to make a meaningful impact on this disease. The time is now.

For this special issue of TMT, authors are invited to submit original manuscripts. These include use cases and unpublished research. In addition, manuscripts advancing defensible opinions covering a spectrum of topics from theory to science, technologies and methodologies, pilots and scalable deployments, operations and economics, user experience and Return-on-Adoption, legal and regulatory, transformation and disruption, and ecosystem and societal issues relevant to telehealth innovations in diabetes are encouraged.  Following submission, a world-class peer-review board will provide rapid review (14 days), including constructive commentary to strengthen the work.

Background

Telemedicine (aka telehealth) along with AI (artificial intelligence) and the IoT (Internet-of-Things) are emerging technological tools in the struggle to manage diabetes. 

At its core, telemedicine delivers clinical services from a distance using video teleconferencing, remote patient monitoring, or telephone. Teleconferencing, for example, provides an electronic “face-to-face” encounter in which the healthcare provider and patient see each other while discussing issues and even sharing data (e.g., X-ray and diagnostic test results). With improved digital clarity and device computing power, these visits seamlessly offer patients the convenience of staying at home vs. fighting traffic, searching for parking, and sitting in a crowded waiting room.

Further, the Center for Connected Health Policy succinctly defines telemedicine as, “the use of medical information exchange from one site to another via electronic communications to improve patient’s health status. It is the use of two-way, real time interactive communication equipment to exchange the patient information from one site to another via an electronic communication system. This includes audio and video communications equipment.”2

As the healthcare delivery model shifts from the hospital/clinic to the community/home, we see both the diabetes community and digital health tech companies at the forefront of promising innovations in the fight to cure, if not eliminate diabetes.    Modalities such as continuous glucose monitoring, smart phone apps to aid in insulin dosing and timing, and the artificial pancreas are promising solutions for those struggling daily to manage their diabetes.  Connected health devices/IoT along with bidirectional communication between doctor and patient all advance our fight for a cure.  Evidence of growing acceptance of telehealth was exemplified on January 1, 2018, when the Centers for Medicare and Medicaid (CMS) approved telehealth code 99091 for Remote Patient Monitoring (RPM). It is one more advance in American healthcare and possibly in the fight for diabetes care management. 

It appears that over the next 5 to 10 years the management of diabetes will follow a trajectory towards a less invasive method for glucose monitoring with tighter and more accurate control of glucose levels.  As technologies progress and the latest innovations for insulin dose management become mainstream, accessible, and more affordable, we might be able to leverage these data.  The objective is to use data to drive meaningful change in behavior so that people living with diabetes thrive, not just survive.   When used effectively, telemedicine improves patient access, enhances communication, and demonstrates cost savings throughout the ecosystem. We believe all this can benefit people living with diabetes.

Reference

  1. Skyler JS, Bakris , GL, Ezio Bonifacio E. Differentiation of diabetes by

pathophysiology, natural history, and prognosis. Diabetes. 2017 Feb; 66(2): 241-

  1. URL: https://diabetes.diabetesjournals.org/content/66/2/241#aff-1

 

  1. 2. Freeborn D, Dyches T, Roper SO. Lessons Learned From a Life With Type 1

Diabetes: Adult Perspectives. Diabetes Spectr. 2017 Aug;30(3):188-194. doi:

10.2337/ds16-0032. PubMed PMID: 28848313; PubMed Central PMCID: PMC5556582.

 

Scope and Topics

Following the examples of previously published papers in Telehealth and Medicine Today (TMT), authors are invited to submit only original, unpublished research results, position papers, guidelines, use reports, failed research attempts, educational teachings, updates, market research, case studies, and educational tools. Papers are invited that exclusively address digital health innovations in healthcare and all converging technologies. No white papers, advertorials, or press releases will be accepted. Be certain your paper is evidence based, original (meaning has NOT  published elsewhere, including parts previously published on websites), and referenced in the Vancouver style.

Topic areas include, but are not limited to focus areas below. Please note, these include all technologies that converge with telehealth, exclusively in healthcare. 

TMT Editorial Focus:

Manuscripts of interest will present local and global innovations fostering ecosystem efficiencies in virtual care, telecare, and telehealth utilizing evidence-based outcomes for:

New Business Models, Provider strategies, incentive models, future society transformation strategies, hardware, software and technology selection, financial Impact to health systems and patient out-of-pocket cost, scalability, sustainability.

Technology: Blockchain and DLT, artificial intelligence, robotics, voice interface tech, augmented reality, machine learning, identity management, smart contracts, security, interoperability, standards, scalability, business continuity

USE CASES: use case discovery frameworks, use case roadmaps, key learnings from successful and unsuccessful experiences

Legal and Regulatory: Reimbursement, reduced hospital readmissions, interoperability, mobile health, devices, EMR, health and wellness consumer protection, health policy, patient privacy (GDPR and HIPAA)

HEALTH IT: Electronic health records (EHR), health information exchange (HIE), interoperatbility, claim adjudication, clinical trials, medical devices, Internet of Things (IoT), wearables, sensors, smart health cities and medically fit homes

Home Care: Long-term care, care giver strategies, remote health, smart cities, sensors, workforce 

Drug Discovery: Protocol development, clinical study management, devices, sensors, data aggregation,

Security and Governance: Oversight, workflow, staffing solutions, recruitment, scaling, monitoring, and maintaining of security systems

Trending Specialties: Population health, chronic condition management, behavioral health, Tele-dermatology, Tele-radiology, Tele-pathology, smart cities and ecosystems for mid-life and beyond 

USER EXPERIENCE: market and user segmentation, generational demographics, consumerization of healthcare, behavioral considerations, user centered design, adoption drivers and barriers, Return-on-Adoption

EDUCATION: Training tools & tips - the fundamentals, innovation management, managing digital transformation, future workforce, medical education 

Authors around the globe are invited to submit original papers under the following categories:

  • Proof of Concept
  • Use Cases, Pilots
  • Methodologies
  • Production, Deployment
  • Original Clinical Research
  • Original Market Research
  • Narrative/Systematic Reviews/Meta-Analysis
  • Opinions, Perspectives, and Commentary on a current trend or issue impacting the sector
  • Training and Tool Kits

Authorship

TMT follows ICMJE guidelines for authorship. Please click this link to review and determine authorship criteria for your submission. Authors must meet all four criteria to be listed as authors. 

Submission of Papers

Submission Deadline: March 30, 2020 

Please submit your manuscript as soon as it is ready. We review, and will accept them on a rolling basis.

To submit, please click here. Please note, you must first become a TMT registered user to upload your paper.

Fees

There are NO FEES to submit to TMT

Timeline

Submissions are due no later than March 30, 2020. No exceptions. 

The issue will be published in Q1/2020 or before depending on reviewer comments and the length of time it takes authors to make revisions and resubmit manuscript revisions. We ask you respect the time and volunteerism of TMT peer reviewers. 

Benefits to Authors:

Unlike any other journal in this market today, Telehealth and Medicine Today (TMT) continuously pushes the boundaries of technology innovation in scholarly publication and ecosystem practices needed to bring together thought leading academics, pragmatic innovators, and practitioners from the private and public sectors around the world.

As an international peer-review open-access online academic journal, TMT provides the following benefits to authors:

Immediate Broad Exposure Upon Publication

  • International localized TMT Chapters around the world connecting a real world future of health ecosystem
  • Email blast to thousands of community members around the world
  • Press release about the article and author/s. 
  • LinkedIn post that the article was published. 
  • Tweet that the article was published. 
  • Posting of a companion video or podcast introduction of the article’s abstract and complementary information the author wishes to share with readers

Great Ease of Publication

  • Endorsed the American Telemedicine Association
  • Partners with IEEE-SA
  • Accepting submissions on an ongoing, continuous, no-deadline basis
  • Rapid two-week peer-review turn around
  • Establish credibility of the scholarly work as measured by the collaborative work of double blind peer review of internationally renowned reviewers.
  • Broadening the reach to thought leading academics, pragmatic innovators, and practitioners from the private and public sectors around the world
  • Experiencing the benefits from the growing ecosystem led by TMT publisher Partners in Digital Health (PDH)

Competitive Merit Exposure

  • Automatic entry to #ConV2X annual conference Editor’s Choice Award
  • Winner is featured in a podcast interview with TMT’s Editor-in-Chief Dr. John Halamka
  • Featured and promoted in all social and media channels 
  • Winner is announced at the annual #ConV2X conference

Editors

Editors-in-Chief:

Amar Gupta, PhD , MIT Institute of Medical Engineering and Science (IMES)

John Halamka, MD, MS, International Healthcare Innovation Professor, Harvard Medical School, USA

 

TMT Guest Editors:

Wilma Hunt-Watts, DPM, Board Member, American Diabetes Association

Joseph K. Hitt, PhD, CEO, Gox Labs

Reviewers:

TMT Board members and reviewers. Click here to view.